journal article·2025-07-22Open access

Ceragenin Nanogel Coating Prevents Biofilms Formation on Urinary Catheters

Antonio Puertas-Segura, Antonio Laganá, Garima Rathee, Paul Savage, Katerina Todorova, Petar Dimitrov, Iva Pashkuleva, Rui Luís Reis, Gianluca Ciardelli, Tzanko Tzanov

Abstract

Catheter-associated urinary tract infections (CAUTIs) account for 40% of hospital-acquired infections, increasing health risks, patient discomfort, morbidity, and hospitalisation time. Bacterial colonisation may occur both during catheter insertion and prolonged catheterization by microorganisms in the urinary tract, consequently, increasing the bacteriuria risk due to biofilm formation. Nanogels, a class of soft nanocarriers, offer remarkable versatility for developing functional coatings on indwelling medical devices that can efficiently prevent biofilm formation. In this study, we designed an antibacterial and antibiofilm coating by leveraging the ultrasound-assisted assembly and nanogel self-organization on silicone catheters. The nanogel comprising biocompatible gum arabic and poly(diallyldimethylammonium chloride) was used to encapsulate a synthetic broad-spectrum antimicrobial peptide mimetic ceragenin (CSA-131). A coating from this bioactive nanogel was sonochemically built on the catheters without any prior surface modification. In vitro and in vivo assays showed that the coating provided antimicrobial and antibiofilm activity for up to 7 days of catheterization, next to catheter lubricity. Cytotoxicity assessment confirmed the absence of toxic effects, underscoring the biocompatibility of the coating formulation. These findings highlighted the potential of nanogels, combined with ultrasound technology, as an innovative approach for durable antimicrobial and antibiofilm functionalization of urinary catheters, particularly susceptible to colonisation by microorganisms upon catheterization.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Surfactants and Colloidal Systems · Pickering emulsions and particle stabilization · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Grup de Biotecnologia Molecular i Industrial, Department of Chemical Engineering

Universitat Politècnica de Catalunya

Department of Biomedical and Dental Sciences and Morphofunctional Imaging

University of Messina

Department of Chemistry and Biochemistry

Brigham Young University

Institute of Experimental Morphology, Pathology and Anthropology with Museum

Bulgarian Academy of Sciences

3B’s Research Group−Biomaterials, Biodegradables and Biomimetics, University of Minho

Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine

ICVS/3B’s PT Government Associated Laboratory

Department of Mechanical and Aerospace Engineering

Politecnico di Torino

Funding

Agencia Estatal de Investigaci?n · HORIZON EUROPE Marie Sklodowska-Curie Actions · Instituci? Catalana de Recerca i Estudis Avan?ats

References (43)

Show source-provided references
1. 10.1038/s41598-020-71834-w10.1038/s41598-020-71834-w ↗
2. 10.1080/1120009x.2017.138039510.1080/1120009x.2017.1380395 ↗
3. 10.3390/coatings1001002310.3390/coatings10010023 ↗
4. 10.1039/D4RA00410H10.1039/D4RA00410H ↗
5. 10.1016/j.pmatsci.2023.10116710.1016/j.pmatsci.2023.101167 ↗
6. 10.1039/c0sm01307b10.1039/c0sm01307b ↗
7. 10.1002/adfm.20200409810.1002/adfm.202004098 ↗
8. 10.3390/pharmaceutics1503075910.3390/pharmaceutics15030759 ↗
9. 10.1021/acsami.1c1261710.1021/acsami.1c12617 ↗
10. 10.1081/MC-10010777510.1081/MC-100107775 ↗
11. 10.1039/C5CS00477B10.1039/C5CS00477B ↗
12. 10.1016/j.ijantimicag.2015.08.00310.1016/j.ijantimicag.2015.08.003 ↗
13. 10.1186/s12951-015-0093-510.1186/s12951-015-0093-5 ↗
14. 10.1021/ar700270t10.1021/ar700270t ↗
15. 10.3390/nano1111314310.3390/nano11113143 ↗
16. 10.1016/j.ultsonch.2024.10713110.1016/j.ultsonch.2024.107131 ↗
17. 10.1021/ja973881r10.1021/ja973881r ↗
18. 10.3390/pharmaceutics1506171710.3390/pharmaceutics15061717 ↗
19. 10.1002/bit.2647510.1002/bit.26475 ↗
20. 10.3390/ijms2314763210.3390/ijms23147632 ↗
21. 10.1016/j.jcis.2023.04.18410.1016/j.jcis.2023.04.184 ↗
22. 10.1063/1.243241010.1063/1.2432410 ↗
23. 10.1021/acsami.4c085910.1021/acsami.4c0859 ↗
24. 10.1021/acsami.4c0571310.1021/acsami.4c05713 ↗
25. 10.3389/fcell.2016.0011110.3389/fcell.2016.00111 ↗
26. 10.3390/antibiotics1202031010.3390/antibiotics12020310 ↗
27. 10.3389/fimmu.2019.0311910.3389/fimmu.2019.03119 ↗
28. 10.1128/aem.02187-2110.1128/aem.02187-21 ↗
29. 10.1016/j.indcrop.2022.11530410.1016/j.indcrop.2022.115304 ↗
30. 10.1021/la502115g10.1021/la502115g ↗
31. 10.1002/anbr.20237007310.1002/anbr.202370073 ↗
32. 10.1007/s10924-023-02821-110.1007/s10924-023-02821-1 ↗
33. 10.1016/j.jmat.2019.01.01210.1016/j.jmat.2019.01.012 ↗
34. 10.1016/j.molliq.2021.11835410.1016/j.molliq.2021.118354 ↗
35. 10.1021/nn200879h10.1021/nn200879h ↗
36. 10.1016/s0022-3093(00)00243-x10.1016/s0022-3093(00)00243-x ↗
37. 10.1016/j.biomaterials.2003.08.01110.1016/j.biomaterials.2003.08.011 ↗
38. 10.3390/ma1509326210.3390/ma15093262 ↗
39. 10.1186/s12951-015-0123-310.1186/s12951-015-0123-3 ↗
40. 10.1002/admi.20240101610.1002/admi.202401016 ↗
41. 10.1111/j.1464-4096.2004.04821.x10.1111/j.1464-4096.2004.04821.x ↗
42. 10.1210/en.2003-069710.1210/en.2003-0697 ↗
43. 10.1016/j.jinf.2012.12.00610.1016/j.jinf.2012.12.006 ↗